Considering stroke etiopathogenesis, we observed a higher percentage of CD4 + T-bet + T cells in peripheral blood from ATHS patients than CES patients and controls (p = 0.0352 and p = 0.0062, respectively; shown in Fig. 1B). The gene discussed is CD4; the disease is stroke disorder.